BridgeBio Oncology Therapeutics Reports Inducement Grants
BridgeBio Oncology Therapeutics reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
BridgeBio Oncology Therapeutics reported inducement grants under Nasdaq Listing Rule 5635(c)(4).